120 related articles for article (PubMed ID: 19656663)
21. Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatment.
Amitai N; Markou A
Pharmacol Biochem Behav; 2009 Sep; 93(3):248-57. PubMed ID: 18809428
[TBL] [Abstract][Full Text] [Related]
22. Chronic administration of quetiapine alleviates the anxiety-like behavioural changes induced by a neurotoxic regimen of dl-amphetamine in rats.
He J; Xu H; Yang Y; Zhang X; Li XM
Behav Brain Res; 2005 May; 160(1):178-87. PubMed ID: 15836913
[TBL] [Abstract][Full Text] [Related]
23. Quetiapine attenuates the depressive and anxiolytic-like behavioural changes induced by global cerebral ischemia in mice.
Yan B; He J; Xu H; Zhang Y; Bi X; Thakur S; Gendron A; Kong J; Li XM
Behav Brain Res; 2007 Aug; 182(1):36-41. PubMed ID: 17568696
[TBL] [Abstract][Full Text] [Related]
24. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats.
Rodefer JS; Murphy ER; Baxter MG
Eur J Neurosci; 2005 Feb; 21(4):1070-6. PubMed ID: 15787711
[TBL] [Abstract][Full Text] [Related]
25. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
Dunn MJ; Killcross S
Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
[TBL] [Abstract][Full Text] [Related]
26. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
Karasawa J; Hashimoto K; Chaki S
Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of combined treatment with risperidone and galantamine on phencyclidine-induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission.
Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
Neuropharmacology; 2007 Sep; 53(3):379-89. PubMed ID: 17632185
[TBL] [Abstract][Full Text] [Related]
28. Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling.
Murai R; Noda Y; Matsui K; Kamei H; Mouri A; Matsuba K; Nitta A; Furukawa H; Nabeshima T
Behav Brain Res; 2007 Jun; 180(2):152-60. PubMed ID: 17451820
[TBL] [Abstract][Full Text] [Related]
29. Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats.
Roseman AS; McGregor C; Thornton JE
Behav Brain Res; 2012 Jul; 233(1):105-12. PubMed ID: 22561127
[TBL] [Abstract][Full Text] [Related]
30. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
31. Alpha-2 adrenoceptor activation inhibits phencyclidine-induced deficits of spatial working memory in rats.
Marrs W; Kuperman J; Avedian T; Roth RH; Jentsch JD
Neuropsychopharmacology; 2005 Aug; 30(8):1500-10. PubMed ID: 15714223
[TBL] [Abstract][Full Text] [Related]
32. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
Abdul-Monim Z; Neill JC; Reynolds GP
J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
[TBL] [Abstract][Full Text] [Related]
33. Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.
Ballmaier M; Zoli M; Mazzoncini R; Gennarelli M; Spano F
Psychopharmacology (Berl); 2001 Dec; 159(1):105-10. PubMed ID: 11797077
[TBL] [Abstract][Full Text] [Related]
34. Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.
Schwabe K; Brosda J; Wegener N; Koch M
Pharmacol Biochem Behav; 2005 Feb; 80(2):213-9. PubMed ID: 15680174
[TBL] [Abstract][Full Text] [Related]
35. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test.
Hirano S; Miyata S; Onodera K; Kamei J
Eur J Pharmacol; 2007 May; 562(1-2):72-6. PubMed ID: 17328889
[TBL] [Abstract][Full Text] [Related]
36. Opposing short- and long-term effects on muscarinic M1/4 receptor binding following chronic phencyclidine treatment.
Newell KA; Zavitsanou K; Huang XF
J Neurosci Res; 2007 May; 85(6):1358-63. PubMed ID: 17342780
[TBL] [Abstract][Full Text] [Related]
37. Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats.
Amitai N; Semenova S; Markou A
Psychopharmacology (Berl); 2007 Sep; 193(4):521-37. PubMed ID: 17497138
[TBL] [Abstract][Full Text] [Related]
38. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
39. Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality.
Svensson TH
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1145-58. PubMed ID: 14642973
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
